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Abstract 
    This paper describes the laws and regulations that affect the practice of energy medicine.  State law 
often has more impact on a health care practice than federal law, but federal law provides a common 
denominator among states.  Device law is emphasized here because practitioners of energy medicine are
more likely to use devices than drugs.  For purposes of this paper, energy medicine is defined as practices 
that measure or benefit energy flow and overall energy in the body.  This broad definition encompasses 
things as diverse as certain forms of exercise, measurement of meridian resistance, the use of electrical 
current or magnetic pulses to relieve pain, and the use of light, sound, scent, touch, position, or movement 
to stimulate the bodyÑs own electrical systems.  What is of greatest importance in determining legal 
implications of a practice is whether there are any health-related claims.  Two federal entities are pivotal.  
The Food and Drug Administration (ÈFDAŠ) is authorized to protect health and safety and the Federal 
Trade Commission (ÈFTCŠ) is authorized to protect consumers from false or misleading advertising.  
There are 5 things that FDA looks at: 1) intended use, 2) claims made in advertising and in labeling, 3) 
substantial equivalence to a predicate, 4) safety, and 5) effectiveness.  A concern regarding any one of 
these can be the basis for denying clearance to market a device.  The FTC looks at whether statements are 
true and substantiated and whether they might be misleading.  The FTC often consults with the FDA on 
the interpretation of technical information.
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Introduction
The regulation of energy medicine is complex and ever-changing.  This paper will soon be outdated, 
though perhaps useful as a page of history.  Many of the citations here are to internet sites that may 
disappear within a year.  New searches will be needed regardless because circumstances are changing so 
rapidly.  This rapid change is partly due to progress in the techniques and instruments of energy medicine, 
partly due to frustration with the allopathic health care system, and partly due to political pressures of the 
various sectors, including health freedom advocates, large corporate interests, and insurance companies.        
Energy medicine can be practiced with objects or substances, but it can also be practiced without any 
physical objects and without physical contact.  Self-treatment is also possible.  There are new practices 
emerging all of the time, though most are based on traditions hundreds or thousands of years old.  When 
entering the realm of the regulation of energy medicine, it is good to have a sense of humor because this 
complex maze of restrictions co-exists with the sparsely regulated world of Èenergy pollutionŠ caused by 
cell phones and other wireless devices, power lines, static charge, etc. There are many internet resources 
relevant to the constantly changing world of energy medicine.  Among the resources is one that appears 
regularly in searches.  The website Quackwatch is by no means an official reference for FDA policies, but 
it often contains information about FDA warning letters and FDA policies.  The articles sometimes track 
or perhaps even foreshadow FDA comments on 510(k) applications, audits, requests for data, and 
enforcement activities.  As might be surmised from the name Quackwatch, the website is derogatory 
toward complementary and alternative medicine, including energy medicine.  The assertions made on this 
website are often defamatory and Quackwatch was successfully sued for defamation in 2007 by Dr. Ted 
Koren, a nationally known chiropractor. [1]   A recent article [2] which discusses warning letters sent by 
FDA to makers of non-invasive devices that measure electrical resistance of acupuncture points (a 
practice related to Traditional Chinese Medicine and a facet of energy medicine), was published in 
October 2011.    As can be seen in this article, Quackwatch continues to defame despite losing the 2007 
litigation.  This recent article will be discussed in more detail below.  If you google Quackwatch, it is 
difficult to find, but if you google a technology, the Quackwatch article will be one of the first items 
listed.
1.1  The Federal Regulation of Devices 
The regulation of devices has much in common with the regulation of drugs, which came much 
earlier.  The Federal Food, Drug, and Cosmetic Act [3] was passed by Congress in 1938 and gives FDA 
authority to oversee the safety of food, drugs, and cosmetics.  In 1976, the Medical Device Regulation 
Act [4] was passed. The Act provided that all devices that were marketed before1976 could be presumed 
to be safe and effective and devices introduced after that had to be found to be safe and effective, as well 
as substantially equivalent to devices that were marketed before the device law was enacted through the 
È510(k)Š process (named after the relevant section of the Act).  In practice, it is not necessary to return to 
the marketplace of 1976 to meet the requirement of substantial equivalence.  A device need only be 
substantially equivalent to a device that has already been ÈclearedŠ for marketing.  FDA law requires a 
more detailed review for products that present a significant risk or are significantly different in terms of 
design, material, chemical composition, energy source, manufacturing process, or intended use.  When 
there is the possibility of significant risk or significant change, premarket approval (ÈPMAŠ) is required.  
The level of detail required in a PMA approaches that of a new drug application.  Only a small percentage 
of devices go this route, as it is very costly.
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      As of 2007, devices are divided into 3 classes.  Class I products do not require premarket clearance 
but an establishment that manufactures the products must be registered and must comply with general 
standards.  Dental floss or bed sheets for hospital beds are examples of products in Class I.  Class II 
products must go through the 510(k) process.  Acupuncture needles and most non-invasive measuring 
devices are in Class II.  Class III devices tend to be invasive (implants) or otherwise raise major safety 
concerns (defibrillators).  Some products are a combination of drug and device.  Whether drug law or 
device law applies is determined by which aspect predominates.   FDA prefers to treat combination 
products as drugs. [5]  For a 510(k), FDA may require data that demonstrates safety and effectiveness, 
either because of risks inherent in the use or because it is not possible to draw conclusions about safety or 
effectiveness because of novelty of the device or its use.  It is best to check whether FDA has issued a 
guidance document that describes data required for the applicable product category.   
1.2  The Pervasiveness of the Current Federal Paradigm 
     While the Food and Drug Administration is the federal agency with the greatest influence over the 
practice of energy medicine, there are also indirect forms of regulation that are driven by the same forces.  
For example, IRS uses essentially the same tests that FDA uses for determining what is ÈmedicalŠ and 
what is not.
ÈIf you itemize your deductions on Form 1040, Schedule A (PDF), you may be able to deduct 
expenses you paid that year for medical care (including dental) for yourself, your spouse, and 
your dependents. A deduction is allowed only for expenses primarily paid for the prevention or 
alleviation of a physical or mental defect or illness. Medical care expenses include payments for 
the diagnosis, cure, mitigation, treatment, or prevention of disease, or treatment affecting any 
structure or function of the body. The cost of drugs is deductible only for drugs that require a 
prescription, except for insulin. . . .Š [6]  
1.3  Freedom of Religion 
      When a medical device is part of a spiritual practice, such as in the case of galvanic skin resistance 
measurements used in Scientology, the medical device is regulated but the spiritual practice is not.   (See 
[7] and [8] vs. [9] for 2 perspectives.)  Medical devices are rarely an issue in freedom of religion.    
ÈLaying on of handsŠ has been around for centuries.   There are also hands-off spiritual energy practices 
that originated in Japan in the 20th century, such as Johrei [10] and Sukyo Mahikari [11].  These practices 
do not make medical claims, though health usually improves. These practices are protected by the right to 
freedom of religion guaranteed by the US ConstitutionÑs Bill of Rights.  Because there are no drugs or 
devices, and because the claims are of a religious nature, FDA has no basis for authority.   There are also 
secular practices that address the spirit-mind-body connections.  So long as they do not make health 
claims and do not involve devices, there is no basis for FDA intervention.  A pioneer who brought the 
connection of spirit/mind/body into mainstream consciousness in the United States was Louise Hay with 
ÈYou Can Heal Your LifeŠ[12].  
 
1.4  Other Aspects of Energy Medicine not Regulated by a Federal Agency 
     While the Food and Drug Administration has authority over medical devices and some of these 
devices impact energy medicine, the majority of practices intended to affect the bodyÑs energy flow do 
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not involve devices.  Exercise that might be considered energy medicine may  require an instructor to be 
trained and authorized to teach the technique (Pilates, Tai Chi).  Some practices rely on manipulation 
(Alexander Technique, Cranial-sacral), some on movement (Feldenkrais, FlexAware), on positions 
(yoga), or scents (aroma therapy).  Some practices that focus on particular areas of the body require 
touching (massage, reflexology, Reiki) and some do not require touching (medical Qigong).   When new 
techniques are introduced, those practicing established techniques often try to protect their turf by making 
newcomers meet extraneous requirements.  For example, massage lobbyists in some states have 
succeeded in having reflexology categorized as massage even though reflexology focuses on Ètrigger 
pointsŠ on the feet, hands, and ears and no other part of the body.  Licensing for massage often requires 
massage training and certification.  To require reflexologists to be licensed as massage therapists is 
needlessly burdensome.  Regulating the practice of medicine is the responsibility of state and local 
authorities.  In most states, there are licensing requirements for most modalities related to health, usually 
administered by a ÈhealthŠ department.  In some states, fitness instructors must also be licensed.  
Licensing is often supplemented by certification by boards that evaluate competence or fulfillment of 
training requirements, e.g., acupuncturists and chiropractors.  Some modalities, e.g., yoga, do not 
normally require state licensing but normally involve some kind of certification process.  Although 
alternative and complementary medical practices are regulated in most states, at least 8 states have 
enacted health freedom laws or amendments to the state Constitution that allow consumers to choose any 
health care practice.  [13]    While consumers may have the right to choose, this right is distinct from a 
practitionerÑs right to practice.  Alaska, Colorado, Georgia, Massachusetts, New York, North Carolina, 
Ohio, Oklahoma, Oregon, Texas, and Washington protect patient access to alternative therapies from 
licensed physicians.  Because many practitioners of energy medicine are not licensed physicians, some 
states have gone much further in protecting the reality of health freedom.  (See 
http://www.cancure.org/legislation_already_passed.htm and links therein.  As of this writing, Florida and 
Minnesota laws provide the greatest freedom, though other states may have a tradition of health freedom 
that is not codified and therefore harder to discover or articulate.)  There are many energy practices that 
do not involve devices.  Reiki is a hands-on energy medicine practice that originated in Japan in the 20th
century [14].   Medical Qigong is a hands-off practice that originated in China centuries ago [15].  
The World of Claims 
2.1  Making Claims 
      Claims are statements about a product or technique that are used in marketing or labeling and that lead 
to expectations.  Thus, disappointed and angry consumers can be a major source of enforcement actions.  
One way to avoid irate consumers is honoring money-back guarantees.  Not every tool of energy 
medicine is, by its intrinsic nature, a medical device, so claims can be pivotal.  From the viewpoint of 
regulatory authorities, multi-purpose objects like bells, tuning forks, colored lights, and jewelry are things 
that can be made into medical devices only by their use and the claims made about their use.  The litmus 
test is whether a device will Èdiagnose, cure, mitigate, treat, or prevent a disease or treat the body in a 
way that affects its structure or function.Š   If a device is claimed to do any one of these things, it will 
most likely be seen by FDA as a medical device, analogous to the finding that Cheerios and walnuts were 
being marketed as drugs, discussed below.  Conversely, there are also some things that, by their nature, 
are undeniably medical devices regardless of the claims not made.  The device that measured changes in 
the galvanic resistance of skin when current was applied, when routinely used in the practice of 
Scientology, was still considered a medical device by FDA.  While the practice was permitted to continue 
with certain stipulations that would keep it legal, a citizen complaint is causing FDA to take another look 
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at what is actually being practiced.  (For a discussion of the 1960Ñs case and recent developments, see 
[16].)    While these examples are illuminating, it is also illuminating to consider the larger picture.  For 
example, despite ample evidence that lie detectors are not reliable indicators of truth, they are still 
permitted to be used.  Another example is the widespread use of microwaves despite ample evidence of 
serious health effects, particularly in the very young.  [17, 18]
2.2 Substantiating Health Claims 
    Claims must be true and their truth must be substantiated.  Even if a claim is substantiated but 
considered to be exaggerated, the Federal Trade Commission can bring an enforcement action for making 
false or misleading claims.  Regardless of whether the claim is bold, vague, implied, or made by another 
though a testimonial, it must not be false or misleading.  How the FTC determines what is false or 
misleading is reviewing ÈsubstantiationŠ files that the claimant is required to keep.  The FTC will often 
turn to FDA for determinations of whether a claim is based on sound science.  Even if a claim is true, 
failure to have a substantiation file is a violation in and of itself.  (See [19].)  Any practitioner who makes 
claims derived from the claims of another (such as the claims by a manufacturer of a device or an 
institution that certifies competence) would be wise to inquire about whether substantiation files are kept 
on these claims.  The practitioner might even want to request a copy of the substantiation file.  In addition 
to federal prosecution, exaggerated or unsubstantiated claims may expose the practitioner or device 
manufacturer to the risk of being sued by patients.  ÈClaimsŠ can be made by implication using anecdotes 
or testimonials.  The party who publicizes anecdotes or testimonials, as well as the parties who give them, 
share responsibility for making the claims.  Even though anecdotes or testimonials may be true and 
substantiated, FDA will not consider them to be scientific proof unless they are the result of a test design 
that meets the rigorous standards of science and statistics.  The FTC defers to the FDA for matters 
involving science, so it is unlikely that the FTC would consider anecdotal evidence to be substantiation, 
though carefully drafted language that discloses the anecdotal nature of the evidence might satisfy FTC or 
be considered a showing of good faith.  State law may be relevant as well.  
2.3  Avoiding Health Claims to Avoid FDA Authority 
      Sometimes people deliberately avoid making health claims to avoid triggering FDAÑs authority.  One 
can claim ÈwellnessŠ and assisting specific mechanisms of action (for example, ORAC results for various 
fruits is a measure of their ability to reduce oxidative stress).  Whatever words are used, the implications 
to avoid are Èdiagnose, cure, mitigate, treat, or prevent a disease or treat the body in a way that affects its 
structure or functionŠ. Examples of words that have meaning in the realm of energy medicine and that 
might be safe (one can never be sure) as claims include: 
resonates with/enhances/supports the bodyÑs systems/ performance/efficiency; 
increases/enhances vitality/clarity/efficiency/well-being;                                   
each personÑs response is unique;  
reduces stress/influence of outside fields/forces/substances. 
      In 2009 and 2010, FDA began enforcement actions using warning letters for the health claims made 
for Cheerios and Diamond walnuts, respectively.  For Cheerios, FDA found health claims related to lower 
cholesterol (e.g., Èyou can lower your cholesterol 4% in 6 weeksŠ) to be a drug claim.  The newest claim, 
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negotiated with FDA, in addition to claims about what Cheerios contain, is ÈThree grams of soluble fiber 
daily from whole grain oat foods, like Cheerios cereal, in a diet low in saturated fat and cholesterol, may 
reduce the risk of heart disease.  Cheerios cereal provides one gram per serving.Š [20]    Similarly for 
Diamond walnuts, FDA found statements relating to the benefits of omega-3 fatty acids (lower
cholesterol, protect against heart disease, ease arthritis and other inflammatory diseases, fight depression 
and other mental illnesses, inhibit tumor growth promoted by the fatty acids in other fats, lower the 
incidence of breast cancer) to be health claims, making walnuts, as marketed, a drug. [21]   
2.4  Changing Claims, Reporting Problems 
      When a manufacturer makes claims about its device, it is natural for a practitioner who uses the 
device to make these same claims.  Sometimes, either because of an FDA Èwarning letterŠ or for other 
reasons, a manufacturer will change its claims.  Broader or new claims will probably require a new 
application to be filed with FDA, even though the device is already cleared for marketing.  Clients should 
be informed of these new claims if the device can be used according to the new claims.  A manufacturer 
has an obligation to inform its customers of the change in claims if they are made narrower or more 
modest in response to a warning letter.  Do the customers have an obligation to change their claims 
accordingly?  Though FDA does not normally take action against practitioners, it can and has.  FDA 
officials have confiscated equipment and records of practitioners.   (See, for example, [22].) If a 
practitioner discovers things about a medical device, unless there is an agreement to the contrary, he or 
she is under no obligation to inform the manufacturer.  So long as the practitioner keeps substantiation 
files and complies with FDA requirements, a practitioner can make new claims, though they may need to 
obtain clearance from FDA first.   Should a practitioner see Èsignificant adverse events or product 
problems,Š the requirements are different.  A report must be made to MedWatch. [23]  
The Process for Getting FDA Clearance  
      The following is a brief overview of FDAÑs process, described on its website [24].  The website has 
links for industry, health care providers, and consumers.
3.1 Research and Testing 
      If we look at the development of an energy medicine device or a practice, it almost always begins 
with research and testing.  This phase is not immune from regulation.  FDA requires the use of an 
institutional review board to safeguard human subjects, as well as the submission of an IDE, 
Investigational Device Exemption, in any situation involving risk.  This IDE allows limited marketing 
(sales of devices at cost only).  Use is limited to that covered by the protocol that has been submitted to 
FDA. [25]   For devices developed in other countries, it is often possible to start with the application 
process.  The most widely used process is the 510(k) application, by which the applicant demonstrates to 
FDAÑs satisfaction that the product is safe and effective and that it is substantially equivalent to one or 
more existing products. In the process of granting clearance, FDA can ask for clarification, design 
changes, or anything else it deems necessary.  The easiest path forward is to comply, though some have 
been successful in resisting FDAÑs opinions, either in the 510(k) process or the Ède novoŠ process.  Once 
ÈclearanceŠ for marketing is obtained, it is legal to sell and use the device, consistent only with the claims 
and information that has been reviewed and cleared by FDA.  In identifying the best ÈpredicateŠ devices, 
it is often necessary to search the FDA database of cleared devices.  Another approach would be to 
contact the manufacturer and ask for the 510(k) number.  Sometimes it is published.  The fact that a 
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product is already being marketed does not necessarily make it a suitable predicate because many devices 
on the market are enforcement actions in the making.  While searching FDAÑs database appears fairly 
straightforward in FDAÑs website, the following things should be kept in mind.  The name of the device 
or its manufacturer may have changed since the original application, in which case the original name is 
needed in order to find the 510(k) number.  In other words, information found on a promising website 
will not necessarily be sufficient to find the predicateÑs 510(k) number, even if a 510(k) application was 
filed and clearance to market was obtained.  Sometimes, for reasons inscrutable, the 510(k) will not come 
up in a search of the FDA database, even if the name of the product and the manufacturer are correct.  
The best way to be certain that a device is not in the database is to look at every device in every Èproduct 
codeŠ that might apply.  For large product categories and overlapping product categories, this is tedious.      
If FDA makes a finding of Èno substantial equivalenceŠ to the predicates named in a 510(k) application, 
the applicant has 90 days to submit an application for de novo review. [26]  A successful de novo review 
generally requires data to show safety and effectiveness.  If an applicant prevails in de novo review, FDA 
might create a new category with a new product code.  As of this writing, FDA is considering 
amendments to the de novo process. [27] If a device is based on new technology or differs substantially 
in safety or effectiveness from what is on the market, the manufacturer needs a Premarket Approval 
(ÈPMAŠ). [28]  The 510(k) submission may be several inches thick and the application fee is more than 
$2,000 for small manufacturers who file an application for the special fee many months in advance and 
more than $4,000 for everyone else.  The PMA may be several feet thick and the application fee is about 
15 times more for small manufacturers and about 50 times more for others.  Some large manufacturers 
seem to prefer to file a PMA because it makes it easier for them to dominate the market.  FDA currently 
presumes that a device that has a PMA is not a suitable predicate for a 510(k).  The fees are adjusted for 
inflation every year.
3.3 A Recent Example 
     Sometimes, FDA will ask for things in its response to an application for reasons that are not apparent.  
In an application filed more than 2 years ago, a foreign company wanted to get clearance for a device that 
measured the resistance of meridians and then used software to help the practitioner interpret the results 
based on Traditional Chinese medicine.  The device was based on work done in the Russian space 
program.  The original goal was to identify and correct energy imbalances during space travel so that 
imbalances would not grow into health problems.  The device was so successful that the returning 
cosmonauts were all able to walk off the spacecraft in good health. The manufacturer of the product based 
on this Russian device had developed a new probe that was spring-loaded to control the pressure, thereby 
improving reliability and comfort.  The probe delivered 1 microAmp of current for 0.2 seconds.  In the 
0.2 seconds, it would make over 200 measurements and average them.  If the deviation of any 
measurement was more than a few per cent, it would ask that the measurement be repeated.  Once the 
measurement had been made, the instrument would emit a noise so that the operator would stop pressing.  
It was therefore easy to repeat measurements without causing discomfort.  The amount of current was so 
small that it could not be felt.  Software would present the data in ways consistent with Traditional 
Chinese Medicine.  The predicate device, which had the word ÈmeridianŠ in its name, did not have a 
spring loaded probe in its earlier models and provided more current for a longer time than the device for 
which the 510k was filed.  It also provided a tone with a pitch that corresponded to the measurement 
value, tempting the practitioner to press harder and harder until the pitch became constant.  It did not take 
long for repeated measurements to become quite painful.  It is important to note that the word ÈmeridianŠ
was part of the predicateÑs name and meridian measurements were its purpose, as was the case for this 
new device.  
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     FDA asked, in addition to various kinds of safety data beyond what had already been developed to 
meet international safety standards, that the new applicant engage in testing to show substantial 
equivalence to the predicate.  FDA wanted clinical data.  It would not accept instead measurements of 
resistors of known resistance, even though resistors provided calibration as well as comparison and did 
not suffer from the moment to moment changes that human subjects have.  This seemed unduly 
burdensome for a device that was probably more safe and effective than its predicate.  The new device 
also had a fiber-optic link (instead of an electrical connection) between the computer and the probe, 
eliminating the hazard of electrical shock.  Even more astonishing, FDA also asked that the word 
ÈmeridianŠ be taken out of all instructions and other labelling -- without explanation.  The manufacturer 
decided to abandon the application because the testing that was requested would be too costly and the 
very purpose of the device would be frustrated by taking out the word Èmeridian.Š  Although FDA was 
asked for an explanation of the meridian comment on 3 occasions, no explanation was ever given.  The 
Quackwatch article cited above [2] concerned EAV (Èelectro-acupuncture according to VollŠ) devices 
that also measure meridian resistance.  The article starts out by dismissing EAV-based devices as Èfancy 
galvanometers, [which] merely measure skin resistance. . .Š  There was no indication that there are 
scientific studies supporting the validity of meridian resistance as a useful indicator of wellness 
parameters.  See [30] for a detailed discussion and additional citations showing that skin resistance is 
lower at acupuncture points along meridians and that resistance changes as other health indicators change.  
The FDA and state enforcement actions that were described in the Quackwatch article ranged from 
warning letters for failure to follow some part of FDA regulations to failing to go through the 510(k) 
process or making claims beyond the claims that had been cleared by FDA.  The predicate is the only 
such product still available in the US, but only because it complied with expensive data requests in recent 
years.
The Future 
There are forces that are contributing to the expanding use of energy medicine.  These forces include 
rapidly rising costs of conventional medical care combined with ever-disappointing outcomes, a 
deepening understanding of why energy medicine works (through biophysics research), the development 
of techniques that validate its success and explain its mechanisms, and an increasing awareness among 
consumers and health care professionals of the value of these less costly and less risky alternatives.  Many 
of these biophysical tools are non-invasive and employ energy levels so low that they cannot be felt.  
Many of them affect causes rather than suppressing symptoms, and may prevent the development of 
costly chronic disease.  Before considering recommendations for the future, it is useful to first have 
clarity about the present.  The following are conjectures and observations about the present.  
4.1  Policies and Trends 
   As discussed in the body of this book, energy can be delivered to the body in many forms, including 
light, sound, electrical currents, magnetic fields, mechanical manipulation, and pressure.  There is no 
threshold of energy intensity currently so low that it could not be regulated if the claims brought it within 
the realm of FDA.  One might ask whether this makes sense, since we are constantly surrounded by 
sources of energy.  These sources of energy may affect us, but unless health claims are made, FDA 
intervenes only if it can show that there is a significant risk.  This may provide a deterrent to reckless 
product designs, but it does not provide much protection from products that cause harm over long periods 
of time or with effects that are not currently monitored.
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1) Although science has provided considerable information about how the body works, it has barely 
scratched the surface of the complexity that surrounds us.  For example, it cannot explain what 
differentiates living and non-living matter.  
2) While the scientific method has the possibility of preventing bias, it provides useful conclusions 
only if a hypothesis is well-formulated, the conditions are appropriately controlled for all 
relevant factors (with emphasis on all), and the results are evaluated without bias.  It is not 
possible to know when these conditions have been met. 
3) Science does not yet have a decent explanation of why the placebo effect is stronger than most 
drugs. 
4) Science cannot adequately account for the roles of attitude and intention, as well as the 
mechanisms by which they work, which may or may not be related to the placebo effect. 
5) There are many non-sequiturs, gaps, dichotomies, and flaws in the formulation of public policy 
and little effort is being made to address these things. 
6) Personal freedom to make health care decisions varies greatly from state to state.    
7) There is no way to take into account in the evaluation of medical practices and devices the 
personal preferences people have for risk-taking, cost, discomfort, and what constitutes disease 
versus aging, yet these are important aspects of safety and effectiveness at the personal level. 
8) The insurance system provides a safety net, but it also puts a very large burden on the economy 
with worse average outcomes in the US than in countries that spend far less on health care.  It 
sometimes gives more authority over health care decisions to bureaucrats than to doctors and 
patients. 
4,2 Options for the Future 
A Fresh Look.  It is time for a fresh look at the regulation of energy medicine.  Important issues that 
should underlie this fresh look are: 1) data requirements commensurate with risks, 2) honoring personal 
choice, 3) the role and cost of insurance, 4) how to best take into account the many gaps in scientific 
understanding. This fresh look will require input from many sectors in order to reach useful conclusions.  
Unifying Safety Standards.  In the world of substances relevant to health, exceptions have been carved 
out for supplements and natural products such as herbs. FDA would like to have more authority in this 
realm, others would like to expand the modalities that are unregulated.   In the area of energy medicine, 
there ought to be energy intensities and energy forms that are presumed safe provided that certain 
conditions are met.  This should have some logical relationship to technologies that are presumed safe but 
barely regulated, such as cell phones, wifi, and smart meters.
Establish guidelines for the use of historical controls such that anecdotal evidence could be more 
easily used.  Everyone has their own unique responses and sensitivities.  Effectiveness may be 
undervalued because of averaging, especially where there are variables not controlled for.  Historical 
controls make individual variations less important.  They also allow smaller sample sizes and reduce the 
incidence of ethical dilemmas caused by effective or dangerous studies.
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Establish simple tests for safety.  FDA, in cooperation with Underwriters Laboratory or other 
appropriate standards organizations, should come up with simple electrical tests that establish safety and, 
if possible, equivalence for devices that are used in energy medicine.  FDA should also develop safety 
standards that, if met, would exempt people from further safety testing, for example, threshold levels of 
current, electromagnetic fields, light, sound, etc. that are considered safe.  Applicants need only show that 
the standards had been met, as determined by an independent testing authority such as UL.  Only efficacy 
would need to be shown with clinical studies.  
Broaden the biofeedback exemption.  The biofeedback exemption should cover any feedback, cognitive 
or non-cognitive, intermittent or continuous, volitional or non-volitional.  There is far more feedback and 
learning that is safe and effective than the biofeedback exemption describes.  
Nomenclature 
ÈEnergy MedicineŠ    Practices that measure or benefit energy flow and overall energy in the 
body, including certain forms of exercise, measurement of meridian resistance, the use of 
electrical current or magnetic pulses to relieve pain, and the use of light, sound, scent, touch, 
position, or movement to stimulate the bodyÑs own electrical systems.
ÈFDAŠ Food and Drug Administration 
ÈFTCŠ Federal Trade Commission
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